DLHL
XBI icon

Donald L. Hagan LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Donald L. Hagan LLC’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,572
Closed -$1.17M – 84
2016
Q2 		$1.17M Buy
+21,572
New +$1.18M 1.13% 15

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Donald L. Hagan LLC's XBI Position: Q3 2016 in Review

Donald L. Hagan LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2016, closing a stake of 21,572 shares — an estimated $1.17M sold.

Donald L. Hagan LLC first reported a position in XBI in Q2 2016 and held it in 1 quarter. The position peaked at $1.17M in Q2 2016. 227 funds tracked by Wall St. Rank hold XBI as of Q3 2016.

  • Donald L. Hagan LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 21,572 State Street SPDR S&P Biotech ETF shares in Q3 2016, an estimated $1.17M.
  • Donald L. Hagan LLC first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 1 quarter.
  • Donald L. Hagan LLC's State Street SPDR S&P Biotech ETF position peaked at $1.17M in Q2 2016.
  • 227 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2016.

Based on Donald L. Hagan LLC's 13F filing for Q3 2016, filed 28 Oct 2016.